Results 1 to 10 of about 114,957 (235)
Implementation of evidence on management of pleural diseases: insights from a territory-wide survey of clinicians in Hong Kong [PDF]
BMC Pulmonary Medicine, 2022 Background Major advances in management of common pleural diseases have taken place in the past decade. However, pleural diseases are often managed by physicians of diverse training background and research on implementation of new knowledge is scanty. We
Macy M. S. Lui +18 more
doaj +2 more sources
Artificial Intelligence in Pleural Diseases: Current Applications and Next Steps [PDF]
Thoracic Research and PracticePleural diseases pose a significant burden on healthcare systems due to diagnostic challenges and high costs. Artificial intelligence (AI) has the potential to provide faster, more accurate, and more reliable results in the diagnosis of these diseases ...
Ferhan Karataş, Öner Dikensoy
doaj +2 more sources
Pleuroparenchymal fibroelastosis in Korean patients: clinico-radiologic-pathologic features and 2-year follow-up [PDF]
The Korean Journal of Internal Medicine, 2021 Background/Aims Pleuroparenchymal fibroelastosis (PPFE) is a type of rare idiopathic interstitial pneumonia that is characterized by predominantly upper lobe involvement with pleural fibrosis and subjacent parenchymal fibrosis.
Jae Ha Lee +4 more
doaj +1 more source
Thoracic Cancer, 2021 Background Malignant pleural mesothelioma (MPM) is a rare, highly aggressive and deadly disease with a poor patient life expectancy. A few years ago, the main challenge was the histological diagnosis of this disease; at present, the search for the best ...
Bertrand Chollet +4 more
doaj +1 more source
Advances in pleural infection and malignancy
European Respiratory Review, 2021 Pleural infection and malignancy are among the most common causes of pleural disease and form the mainstay of pleural practice. There has been significant research and increase in scientific understanding in these areas in the past decade. With regard to
Eihab O. Bedawi +3 more
doaj +1 more source
Breathe, 2023 Malignant pleural disease represents a growing healthcare burden. Malignant pleural effusion affects approximately 1 million people globally per year, causes disabling breathlessness and indicates a shortened life expectancy. Timely diagnosis is imperative to relieve symptoms and optimise quality of life, and should give consideration to individual ...
Laura M. Piggott +3 more
openaire +2 more sources
Respiratory Research, 2020 Background Recurrent malignant pleural effusions (MPE) are common and associated with significant morbidity in cancer patients. A new pump connecting the pleural cavity and the bladder may have application for the management of recurrent MPE.
S. Laroumagne +5 more
doaj +1 more source
Frontiers in Microbiology, 2023 BackgroundThe simple, rapid, and accurate diagnosis of tuberculous pleural effusion (TPE) remains difficult. This study aimed to determine the accuracy of hepatocyte growth factor (HGF) in the diagnosis of TPE.MethodsWe quantified the expression of HGF ...
Sheng-Cai Zheng +9 more
doaj +1 more source
Frontiers in Oncology, 2022 ObjectivePre-treatment biomarkers to estimate overall survival (OS) for malignant pleural effusion (MPE) are unidentified, especially those in pleural fluid.
Xin Qiao +3 more
doaj +1 more source
Pulmonary cement embolism complicating percutaneous kyphoplasty: A case report
Respiratory Medicine Case Reports, 2020 Background: Vertebral cement augmentation procedures, as kyphoplasty (KP) or percutaneous vertebroplasty (PVP), are commonly used for the management of pain of the vertebral column usually due to fractures related to traumatic injury, osteoporosis or ...
Romain Naud +2 more
doaj +1 more source